Evidence map›Paper›PMID 30739223›Full record

ArticleMolecular and cellular biochemistry2019

Phospho-substrate profiling of Epac-dependent protein kinase C activity.

Diana J Goode, Derek C Molliver

Open access · greenAbstract read
In one paragraph

Article in Molecular and cellular biochemistry, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.1field-weighted citation impact, top 55% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Role of EPAC1 in chronic pain.Biochemistry and biophysics reports · 2024
    Review
  3. Review
  4. Regulation of Mitochondrial Function by Epac2 Contributes to Acute Inflammatory Hyperalgesia.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Diana J GoodeDepartment of Biomedical Sciences, University of New England, 11 Hills Beach Rd, Biddeford, ME, 04005, USA.ORCID https://orcid.org/0000-0002-3158-1384
Derek C MolliverDepartment of Biomedical Sciences, University of New England, 11 Hills Beach Rd, Biddeford, ME, 04005, USA. Dmolliver@une.edu.ORCID http://orcid.org/0000-0002-4406-7384
University of New England · US

Funding

Tissue resident macrophages in sensory ganglia: function and impact on nociceptionP20GM103643 · NIGMS · UNIVERSITY OF NEW ENGLAND · PI MENG, IAN D · 2012 to 2021
$20.9M
Purinergic G protein signal integration in nociceptorsR01GM102346 · NIGMS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI MOLLIVER, DEREK C · 2013 to 2016
$1.1M
National Institute of General Medical Sciences NIH P20GM103643National Institute of General Medical Sciences RO1102346NIGMS NIH HHS P20 GM103643NIGMS NIH HHS R01 GM102346
6 · The paper itself

Abstract

Exchange protein directly activated by cAMP (Epac) and protein kinase A are effectors for cAMP with distinct actions and regulatory mechanisms. Epac is a Rap guanine nucleotide exchange factor that activates Rap1; protein kinase C (PKC) is a major downstream target of Epac-Rap1 signaling that has been implicated in a variety of pathophysiological processes, including cardiac hypertrophy, cancer, and nociceptor sensitization leading to chronic pain. Despite the implication of both Epac and PKC in these processes, few downstream targets of Epac-PKC signaling have been identified. This study characterized the regulation of PKC activity downstream of Epac activation. Using an antibody that recognizes phospho-serine residues within the consensus sequence phosphorylated by PKC, we analyzed the 1-dimensional banding profile of PKC substrate protein phosphorylation from the Neuro2A mouse neuroblastoma cell line. Activation of Epac either indirectly by prostaglandin PGE2, or directly by 8-pCPT-2-O-Me-cAMP-AM (8pCpt), produced distinct PKC phospho-substrate protein bands that were suppressed by co-administration of the Epac inhibitor ESI09. Different PKC isoforms contributed to the induction of individual phospho-substrate bands, as determined using isoform-selective PKC inhibitors. Moreover, the banding profile after Epac activation was altered by disruption of the cytoskeleton, suggesting that the orchestration of Epac-dependent PKC signaling is regulated in part by interactions with the cytoskeleton. The approach described here provides an effective means to characterize Epac-dependent PKC activity.

Indexed as

Signal TransductionAnimalsCell Line, TumorCytoskeletonDinoprostoneGuanine Nucleotide Exchange FactorsMicePhosphorylationProtein Kinase Crap1 GTP-Binding ProteinsDinoprostoneEpac protein, mouseGuanine Nucleotide Exchange FactorsProtein Kinase Crap1 GTP-Binding ProteinsRap1 protein, mouseCytoskeletonPhosphorylationProstaglandinsSignal transduction

Identifiers

PMID30739223
PMCPMC7269517
OpenAlexW2912219910

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.